EY helps clients create long-term value for all stakeholders. Enabled by data and technology, our services and solutions provide trust through assurance and help clients transform, grow and operate.
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in the capital markets.
How do you leverage AI to streamline insurance claims?
An insurer harnessed AI to streamline operations and boost agent capabilities.
Continue reading FLM
The better the answer
Transforming insurance claims with human-centric AI
An EY solution that transforms the insurer’s data process by converging business insights, domain knowledge and AI.
Continue reading FLM
The better the working world
Unlocking exponential transformation through AI-driven modernization
The EY team’s AI solution is driving accelerated claim processing, deepened customer relationships, and an enterprise-wide modernization.
Continue reading FLM
close
Strategy, transactions and transformation
EY can help you realize your ambitions by offering a radically different approach to connecting strategy, transactions, transformation and technology, where design and delivery inform each other at every step.
Sustainability is everybody’s business. Explore EY insights to see how your business can reframe sustainability to protect and create new sources of value.
DAVOS, 21 JANUARY 2025. Confidence in growth among global CEOs is increasing despite complex geopolitical and macroeconomic challenges, according to the latest EY-Parthenon CEO Outlook Survey: Global Confidence Index, which evaluates the optimism levels of 1,200 global business leaders based on 15 “Confidence Index" measures.
EY Strategy and Consulting Co., Ltd. (Chiyoda-ku, Tokyo; President and CEO, Akira Kondo; EYSC) supported the planning and operation of a "Survey on the Challenges Faced by Healthcare Professionals in Rare Diseases," in collaboration with Initiative on Rare and Undiagnosed Diseases (IRUD), Rare Disease Consortium Japan (RDCJ), and Japan Pharmaceutical Manufacturers Association (JPMA). EY is pleased to announce that a report of the survey results is now available.
We have identified a website that attempts to deceive visitors by falsely claiming an association with several members of EY Japan.
EY Japan, its member firms, partners and staff members do not recommend or endorse cryptocurrencies, investment schemes or similar.
EY Japan holds various events and seminars covering assurance, consulting, legal affairs, strategy, taxation and transactions and sector-specific information.